Stay updated on Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The developer revision/version displayed on the page was updated from v3.5.2 to v3.5.3, reflecting a backend/site release rather than a change to the trial’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T06:08:29.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision v3.5.2 was added. The previous revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:11.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.0 and removes v3.4.3 from the list.
    Difference
    0.1%
    Check dated 2026-03-19T05:00:18.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision history shows the latest revision is v3.4.3, replacing the previous v3.4.2 entry.
    Difference
    0.1%
    Check dated 2026-03-12T01:41:38.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and older notices such as the funding lapse notice and Revision: v3.4.1 were removed.
    Difference
    0.9%
    Check dated 2026-02-11T14:17:42.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page adds a government funding lapse notice and the record history shows a new version (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-04T10:25:15.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.